share_log

拜耳20亿美元收购美国生物制药商Vividion

Bayer buys US biopharmaceutical company Vividion for $2 billion

新浪財經 ·  Aug 5, 2021 14:06

GermanyBayerThe group announced on Thursday that it would buy US biopharmaceutical company Vividion Therapeutics for up to $2 billion to strengthen its ability to discover new treatments and increase the value of its drug pipeline.

The deal is expected to close in the third quarter. Bayer will pay $1.5 billion first and up to $500m when Vividion's business reaches certain milestones in the future.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment